APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Fractionation and Blood Product

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasma Fractionation and Blood Product Market Outlook and Growth Opportunities 2026

2 January 2026194 pages

Choose your research edition.

Industry ResearchPlasma Fractionation and Blood Product Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Fractionation and Blood Product Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Plasma Fractionation and Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Fractionation and Blood Product Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Fractionation and Blood Product Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Plasma Fractionation and Blood Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasma Fractionation and Blood Product market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasma Fractionation and Blood Product market include Takeda, RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols, CSL and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plasma Fractionation and Blood Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Fractionation and Blood Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Fractionation and Blood Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasma Fractionation and Blood Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Plasma Fractionation and Blood Product Segment by Company

Takeda

RAAS

Octapharma

LFB Group

Kedrion

Hualan Bio

Grifols

CSL

CBPO

BPL

Biotest

Plasma Fractionation and Blood Product Segment by Type

Albumin

Immune Globulin

Coagulation Factor

Other

Plasma Fractionation and Blood Product Segment by Application

Immunology

Hematology

Other

Plasma Fractionation and Blood Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Plasma Fractionation and Blood Product status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plasma Fractionation and Blood Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma Fractionation and Blood Product significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma Fractionation and Blood Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation and Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation and Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Fractionation and Blood Product market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Fractionation and Blood Product industry.

Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plasma Fractionation and Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plasma Fractionation and Blood Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma Fractionation and Blood Product Industry Trends Table 2. Plasma Fractionation and Blood Product Industry Drivers Table 3. Plasma Fractionation and Blood Product Industry Opportunities and Challenges Table 4. Plasma Fractionation and Blood Product Industry Restraints Table 5. Global Plasma Fractionation and Blood Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma Fractionation and Blood Product Revenue Share by Company (2021-2026) Table 7. Global Plasma Fractionation and Blood Product Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Plasma Fractionation and Blood Product Sales Volume Share by Company (2021-2026) Table 9. Global Plasma Fractionation and Blood Product Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Plasma Fractionation and Blood Product Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plasma Fractionation and Blood Product Key Company Manufacturing Base & Headquarters Table 12. Global Plasma Fractionation and Blood Product Company, Product Type & Application Table 13. Global Plasma Fractionation and Blood Product Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Albumin Table 18. Significant Companies of Immune Globulin Table 19. Significant Companies of Coagulation Factor Table 20. Significant Companies of Other Table 21. Global Plasma Fractionation and Blood Product Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Plasma Fractionation and Blood Product Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Plasma Fractionation and Blood Product Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Plasma Fractionation and Blood Product Sales Volume Share by Type (2021-2026) Table 25. Global Plasma Fractionation and Blood Product Sales Volume Share by Type (2027-2032) Table 26. Global Plasma Fractionation and Blood Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasma Fractionation and Blood Product Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Plasma Fractionation and Blood Product Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Plasma Fractionation and Blood Product Sales Value Share by Type (2021-2026) Table 30. Global Plasma Fractionation and Blood Product Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Immunology Table 32. Significant Companies of Hematology Table 33. Significant Companies of Other Table 34. Global Plasma Fractionation and Blood Product Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Plasma Fractionation and Blood Product Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Plasma Fractionation and Blood Product Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Plasma Fractionation and Blood Product Sales Volume Share by Application (2021-2026) Table 38. Global Plasma Fractionation and Blood Product Sales Volume Share by Application (2027-2032) Table 39. Global Plasma Fractionation and Blood Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Plasma Fractionation and Blood Product Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Plasma Fractionation and Blood Product Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Plasma Fractionation and Blood Product Sales Value Share by Application (2021-2026) Table 43. Global Plasma Fractionation and Blood Product Sales Value Share by Application (2027-2032) Table 44. Global Plasma Fractionation and Blood Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Plasma Fractionation and Blood Product Sales by Region (2021-2026) & (K Units) Table 46. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2021-2026) Table 47. Global Plasma Fractionation and Blood Product Sales by Region (2027-2032) & (K Units) Table 48. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2027-2032) Table 49. Global Plasma Fractionation and Blood Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Plasma Fractionation and Blood Product Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Plasma Fractionation and Blood Product Sales Value Share by Region (2021-2026) Table 52. Global Plasma Fractionation and Blood Product Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Plasma Fractionation and Blood Product Sales Value Share by Region (2027-2032) Table 54. Global Plasma Fractionation and Blood Product Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Plasma Fractionation and Blood Product Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Plasma Fractionation and Blood Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 59. Global Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 60. Global Plasma Fractionation and Blood Product Sales by Country (2027-2032) & (K Units) Table 61. Global Plasma Fractionation and Blood Product Sales Market Share by Country (2027-2032) Table 62. Global Plasma Fractionation and Blood Product Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Plasma Fractionation and Blood Product Sales Value Market Share by Country (2021-2026) Table 64. Global Plasma Fractionation and Blood Product Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Plasma Fractionation and Blood Product Sales Value Market Share by Country (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Takeda Plasma Fractionation and Blood Product Product Portfolio Table 70. Takeda Recent Development Table 71. RAAS Company Information Table 72. RAAS Business Overview Table 73. RAAS Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. RAAS Plasma Fractionation and Blood Product Product Portfolio Table 75. RAAS Recent Development Table 76. Octapharma Company Information Table 77. Octapharma Business Overview Table 78. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Octapharma Plasma Fractionation and Blood Product Product Portfolio Table 80. Octapharma Recent Development Table 81. LFB Group Company Information Table 82. LFB Group Business Overview Table 83. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. LFB Group Plasma Fractionation and Blood Product Product Portfolio Table 85. LFB Group Recent Development Table 86. Kedrion Company Information Table 87. Kedrion Business Overview Table 88. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Kedrion Plasma Fractionation and Blood Product Product Portfolio Table 90. Kedrion Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hualan Bio Plasma Fractionation and Blood Product Product Portfolio Table 95. Hualan Bio Recent Development Table 96. Grifols Company Information Table 97. Grifols Business Overview Table 98. Grifols Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Grifols Plasma Fractionation and Blood Product Product Portfolio Table 100. Grifols Recent Development Table 101. CSL Company Information Table 102. CSL Business Overview Table 103. CSL Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CSL Plasma Fractionation and Blood Product Product Portfolio Table 105. CSL Recent Development Table 106. CBPO Company Information Table 107. CBPO Business Overview Table 108. CBPO Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CBPO Plasma Fractionation and Blood Product Product Portfolio Table 110. CBPO Recent Development Table 111. BPL Company Information Table 112. BPL Business Overview Table 113. BPL Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. BPL Plasma Fractionation and Blood Product Product Portfolio Table 115. BPL Recent Development Table 116. Biotest Company Information Table 117. Biotest Business Overview Table 118. Biotest Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Biotest Plasma Fractionation and Blood Product Product Portfolio Table 120. Biotest Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Plasma Fractionation and Blood Product Distributors List Table 124. Plasma Fractionation and Blood Product Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Plasma Fractionation and Blood Product Product Image Figure 2. Global Plasma Fractionation and Blood Product Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plasma Fractionation and Blood Product Sales (2021-2032) & (K Units) Figure 5. Global Plasma Fractionation and Blood Product Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Plasma Fractionation and Blood Product Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Albumin Image Figure 10. Immune Globulin Image Figure 11. Coagulation Factor Image Figure 12. Other Image Figure 13. Global Plasma Fractionation and Blood Product Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Plasma Fractionation and Blood Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Plasma Fractionation and Blood Product Sales Volume Share by Type (2021-2032) Figure 16. Global Plasma Fractionation and Blood Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Plasma Fractionation and Blood Product Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Plasma Fractionation and Blood Product Sales Value Share by Type (2021-2032) Figure 19. Immunology Image Figure 20. Hematology Image Figure 21. Other Image Figure 22. Global Plasma Fractionation and Blood Product Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Plasma Fractionation and Blood Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Plasma Fractionation and Blood Product Sales Volume Share by Application (2021-2032) Figure 25. Global Plasma Fractionation and Blood Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Plasma Fractionation and Blood Product Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Plasma Fractionation and Blood Product Sales Value Share by Application (2021-2032) Figure 28. Global Plasma Fractionation and Blood Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Plasma Fractionation and Blood Product Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Plasma Fractionation and Blood Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Plasma Fractionation and Blood Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 33. North America Plasma Fractionation and Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Plasma Fractionation and Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Plasma Fractionation and Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 39. South America Plasma Fractionation and Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Plasma Fractionation and Blood Product Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Plasma Fractionation and Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Plasma Fractionation and Blood Product Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Plasma Fractionation and Blood Product Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Other
Applications
  • Immunology
  • Hematology
  • Other
Companies covered
  • Takeda
  • RAAS
  • Octapharma
  • LFB Group
  • Kedrion
  • Hualan Bio
  • Grifols
  • CSL
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasma Fractionation and Blood Product Sales Value (2021-2032)
  4. 1.2.2 Global Plasma Fractionation and Blood Product Sales Volume (2021-2032)
  5. 1.2.3 Global Plasma Fractionation and Blood Product Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plasma Fractionation and Blood Product Market Dynamics
  1. 2.1 Plasma Fractionation and Blood Product Industry Trends
  2. 2.2 Plasma Fractionation and Blood Product Industry Drivers
  3. 2.3 Plasma Fractionation and Blood Product Industry Opportunities and Challenges
  4. 2.4 Plasma Fractionation and Blood Product Industry Restraints
3 Plasma Fractionation and Blood Product Market by Company
  1. 3.1 Global Plasma Fractionation and Blood Product Company Revenue Ranking in 2025
  2. 3.2 Global Plasma Fractionation and Blood Product Revenue by Company (2021-2026)
  3. 3.3 Global Plasma Fractionation and Blood Product Sales Volume by Company (2021-2026)
  4. 3.4 Global Plasma Fractionation and Blood Product Average Price by Company (2021-2026)
  5. 3.5 Global Plasma Fractionation and Blood Product Company Ranking (2024-2026)
  6. 3.6 Global Plasma Fractionation and Blood Product Company Manufacturing Base and Headquarters
  7. 3.7 Global Plasma Fractionation and Blood Product Company Product Type and Application
  8. 3.8 Global Plasma Fractionation and Blood Product Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plasma Fractionation and Blood Product Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plasma Fractionation and Blood Product Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plasma Fractionation and Blood Product Market by Type
  1. 4.1 Plasma Fractionation and Blood Product Type Introduction
  2. 4.1.1 Albumin
  3. 4.1.2 Immune Globulin
  4. 4.1.3 Coagulation Factor
  5. 4.1.4 Other
  6. 4.2 Global Plasma Fractionation and Blood Product Sales Volume by Type
  7. 4.2.1 Global Plasma Fractionation and Blood Product Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plasma Fractionation and Blood Product Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Plasma Fractionation and Blood Product Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Plasma Fractionation and Blood Product Sales Value by Type
  11. 4.3.1 Global Plasma Fractionation and Blood Product Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Plasma Fractionation and Blood Product Sales Value by Type (2021-2032)
  13. 4.3.3 Global Plasma Fractionation and Blood Product Sales Value Share by Type (2021-2032)
5 Plasma Fractionation and Blood Product Market by Application
  1. 5.1 Plasma Fractionation and Blood Product Application Introduction
  2. 5.1.1 Immunology
  3. 5.1.2 Hematology
  4. 5.1.3 Other
  5. 5.2 Global Plasma Fractionation and Blood Product Sales Volume by Application
  6. 5.2.1 Global Plasma Fractionation and Blood Product Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Fractionation and Blood Product Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Plasma Fractionation and Blood Product Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Plasma Fractionation and Blood Product Sales Value by Application
  10. 5.3.1 Global Plasma Fractionation and Blood Product Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plasma Fractionation and Blood Product Sales Value by Application (2021-2032)
  12. 5.3.3 Global Plasma Fractionation and Blood Product Sales Value Share by Application (2021-2032)
6 Plasma Fractionation and Blood Product Regional Sales and Value Analysis
  1. 6.1 Global Plasma Fractionation and Blood Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Fractionation and Blood Product Sales by Region (2021-2032)
  3. 6.2.1 Global Plasma Fractionation and Blood Product Sales by Region: 2021-2026
  4. 6.2.2 Global Plasma Fractionation and Blood Product Sales by Region (2027-2032)
  5. 6.3 Global Plasma Fractionation and Blood Product Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plasma Fractionation and Blood Product Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plasma Fractionation and Blood Product Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plasma Fractionation and Blood Product Sales Value by Region (2027-2032)
  9. 6.5 Global Plasma Fractionation and Blood Product Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plasma Fractionation and Blood Product Sales Value (2021-2032)
  12. 6.6.2 North America Plasma Fractionation and Blood Product Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plasma Fractionation and Blood Product Sales Value (2021-2032)
  15. 6.7.2 Europe Plasma Fractionation and Blood Product Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plasma Fractionation and Blood Product Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plasma Fractionation and Blood Product Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plasma Fractionation and Blood Product Sales Value (2021-2032)
  21. 6.9.2 South America Plasma Fractionation and Blood Product Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plasma Fractionation and Blood Product Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plasma Fractionation and Blood Product Sales Value Share by Country, 2025 VS 2032
7 Plasma Fractionation and Blood Product Country-level Sales and Value Analysis
  1. 7.1 Global Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma Fractionation and Blood Product Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plasma Fractionation and Blood Product Sales by Country (2021-2032)
  4. 7.3.1 Global Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  5. 7.3.2 Global Plasma Fractionation and Blood Product Sales by Country (2027-2032)
  6. 7.4 Global Plasma Fractionation and Blood Product Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plasma Fractionation and Blood Product Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plasma Fractionation and Blood Product Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plasma Fractionation and Blood Product Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plasma Fractionation and Blood Product Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plasma Fractionation and Blood Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 RAAS
  8. 8.2.1 RAAS Company Information
  9. 8.2.2 RAAS Business Overview
  10. 8.2.3 RAAS Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
  12. 8.2.5 RAAS Recent Developments
  13. 8.3 Octapharma
  14. 8.3.1 Octapharma Company Information
  15. 8.3.2 Octapharma Business Overview
  16. 8.3.3 Octapharma Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
  18. 8.3.5 Octapharma Recent Developments
  19. 8.4 LFB Group
  20. 8.4.1 LFB Group Company Information
  21. 8.4.2 LFB Group Business Overview
  22. 8.4.3 LFB Group Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
  24. 8.4.5 LFB Group Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Grifols
  38. 8.7.1 Grifols Company Information
  39. 8.7.2 Grifols Business Overview
  40. 8.7.3 Grifols Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
  42. 8.7.5 Grifols Recent Developments
  43. 8.8 CSL
  44. 8.8.1 CSL Company Information
  45. 8.8.2 CSL Business Overview
  46. 8.8.3 CSL Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CSL Plasma Fractionation and Blood Product Product Portfolio
  48. 8.8.5 CSL Recent Developments
  49. 8.9 CBPO
  50. 8.9.1 CBPO Company Information
  51. 8.9.2 CBPO Business Overview
  52. 8.9.3 CBPO Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
  54. 8.9.5 CBPO Recent Developments
  55. 8.10 BPL
  56. 8.10.1 BPL Company Information
  57. 8.10.2 BPL Business Overview
  58. 8.10.3 BPL Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BPL Plasma Fractionation and Blood Product Product Portfolio
  60. 8.10.5 BPL Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Plasma Fractionation and Blood Product Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
  66. 8.11.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plasma Fractionation and Blood Product Value Chain Analysis
  2. 9.1.1 Plasma Fractionation and Blood Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plasma Fractionation and Blood Product Sales Mode & Process
  6. 9.2 Plasma Fractionation and Blood Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plasma Fractionation and Blood Product Distributors
  9. 9.2.3 Plasma Fractionation and Blood Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst